A Strong Season for Vaccines

Novartis said today it will pay up to $500 million to license an experimental vaccine to help people quit smoking. The vaccine, from a Swiss biotech company called Cytos, is in clinical trials.

External Link: http://blogs.wsj.com/health/2007/04/25/a-strong-season-for-v...